In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

X-Cell Medical: Putting Safety First

Executive Summary

Most medical device start-ups seeking to tap into the enormous drug-eluting stent market have focused on novel stent or stent platform design, on the theory that drug efficacy is a given. But X-Cell Medical is betting that they've come up with a better drug. And they're making their case by stressing the importance of safety.
Advertisement

Related Content

Industry Perspective - The Medtech Industry: A Look Back at 2006
TCT Highlights: Late Stent Thrombosis Controversy Continues
Building Billion-Dollar Businesses: An Interview with Robert Croce
Building Billion-Dollar Businesses: An Interview with Robert Croce
Will Late Loss Debate Stifle Device Start-Up Innovation?
At PCR, How Big is Small?
ATI: Is This the Model for Device Development?
ATI: Is This the Model for Device Development?
Guidant's Guiding Spirit: An Interview with Beverly Lorell, MD
Guidant's Guiding Spirit: An Interview with Beverly Lorell, MD

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel